Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.
Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check49 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check63 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference13%
- Check78 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and an extensive selection of data fields for studies.SummaryDifference16%
Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.